First Eagle Investment Management LLC Acquires 17,881 Shares of Colgate-Palmolive Company $CL

First Eagle Investment Management LLC increased its holdings in Colgate-Palmolive Company (NYSE:CL) by 0.2% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 7,889,103 shares of the company’s stock after buying an additional 17,881 shares during the quarter. First Eagle Investment Management LLC owned about 0.98% of Colgate-Palmolive worth $630,655,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Brighton Jones LLC lifted its position in Colgate-Palmolive by 4.4% during the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after purchasing an additional 450 shares during the period. Woodline Partners LP raised its stake in Colgate-Palmolive by 76.3% during the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company’s stock valued at $4,344,000 after buying an additional 20,062 shares during the last quarter. Schnieders Capital Management LLC. lifted its holdings in shares of Colgate-Palmolive by 2.0% during the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company’s stock valued at $1,136,000 after buying an additional 245 shares during the period. Hantz Financial Services Inc. boosted its stake in shares of Colgate-Palmolive by 63.9% in the 2nd quarter. Hantz Financial Services Inc. now owns 1,616 shares of the company’s stock worth $147,000 after buying an additional 630 shares during the last quarter. Finally, Assetmark Inc. grew its holdings in shares of Colgate-Palmolive by 25.5% in the second quarter. Assetmark Inc. now owns 21,117 shares of the company’s stock worth $1,920,000 after acquiring an additional 4,292 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.9%

Shares of Colgate-Palmolive stock opened at $97.23 on Tuesday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $100.18. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The company has a market capitalization of $78.37 billion, a P/E ratio of 37.11, a P/E/G ratio of 4.47 and a beta of 0.28. The company has a fifty day moving average of $87.86 and a 200 day moving average of $82.78.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the firm earned $0.91 earnings per share. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 79.39%.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a report on Tuesday, December 9th. Morgan Stanley increased their price objective on shares of Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. The Goldman Sachs Group restated a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 20th. Argus reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Finally, Bank of America lifted their price target on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Eleven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 97,843 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 over the last ninety days. 0.41% of the stock is owned by corporate insiders.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate’s 2030 Strategic Plan and an analyst rating upgrade reinforce the company’s long‑term growth story (brand focus, science‑driven product development and omnichannel execution), which helped shares rally into the plan reveal. Colgate Palmolive (CL) Valuation Check After 2030 Plan Reveal And Analyst Rating Upgrade
• Neutral Sentiment: Market strategists are flagging broader equity risk as the Iran conflict evolves; that raises overall market volatility but consumer staples like Colgate often outperform cyclicals in such environments. Iran escalation compounds AI and credit worries, Barclays’ Cau warns
• Negative Sentiment: Former Treasury Secretary Janet Yellen warned the Iran conflict could slow U.S. growth and push up inflation, reducing the Fed’s room to cut rates — a backdrop that can weigh on valuation multiples for many stocks, including consumer names. Yellen says Iran conflict puts Fed on hold, complicates rate cuts
• Negative Sentiment: Rising oil and gas expectations due to risks around the Strait of Hormuz increase input and transportation cost pressure for packaged‑goods companies, which can compress margins if not passed through to consumers. Oil, gas seen rising as Hormuz risks mount after U.S., Israel-Iran strikes
• Negative Sentiment: Shipping disruptions are intensifying (major Japanese carriers have suspended Persian Gulf operations), raising short‑term supply‑chain and logistics risks that could increase costs or delay inventory flows for multinational consumer firms. Japanese shipping giants pull back as Strait of Hormuz ’practically closes’
• Negative Sentiment: Analysts are repricing energy exposure as geopolitical risk lifts oil risk premia (BofA raised price targets on oil majors), signaling higher fuel and transport costs that can pressure margins for consumer staples. Chevron, Exxon price targets raised at BofA on increased oil risk premium

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.